| Scenario | Inputs | Output (Dose / Vials / Drug Volume) |
|---|---|---|
| Fixed Q3W | Fixed schedule: 1200 mg every 3 weeks | 1200 mg • 1×1200 + 0×840 • 20.00 mL |
| Fixed Q4W | Fixed schedule: 1680 mg every 4 weeks | 1680 mg • 1×1200 + 1×840 • 28.00 mL |
| Weight-based estimate | 70 kg • 15 mg/kg • no cap | 1050 mg • 0×1200 + 2×840 (min waste) • 17.50 mL |
- Fixed dosing: Dose (mg) is selected directly (840, 1200, or 1680).
- Weight-based estimate: Dose (mg) = Weight (kg) × 15.
- Drug volume: Volume (mL) = Dose (mg) ÷ 60 (mg/mL).
- Final concentration (estimate): Concentration (mg/mL) = Dose (mg) ÷ Bag volume (mL).
- Vial planning: Choose 1200 mg and 840 mg vials to meet or exceed the dose with minimal waste.
- Select the dosing method. Use fixed schedules unless your protocol specifies otherwise.
- If using weight-based estimation, enter weight in kilograms and choose cap/rounding options per policy.
- Enter the planned infusion bag volume to estimate final concentration.
- Choose whether this is the initial infusion to display the typical infusion duration.
- Press Calculate Dose. Review warnings, vial plan, and concentration checks carefully.
- Use Add to Log to build a table, then export to CSV or PDF for documentation.
Clinical dosing patterns and schedule selection
Atezolizumab is commonly administered as a fixed dose on 2‑, 3‑, or 4‑week cycles, enabling predictable chair time and standardized pharmacy workflows. In practice, schedule choice is driven by indication, combination partners, visit frequency preferences, and capacity constraints. Fixed dosing reduces calculation variability and simplifies verification, while still allowing clinicians to tailor supportive care and monitoring intervals.
When therapy is held for toxicity, resumption should follow protocol-defined criteria rather than recalculating dose. Renal or hepatic impairment does not usually mandate dose reductions, but clinical judgment, laboratory trends, and adverse-event grading remain essential safeguards alongside any automated tool in routine adult oncology practice.
Estimating exposure with mg/kg context
Although fixed dosing is standard, comparing the selected dose to an implied mg/kg value can reveal outliers that warrant a double check of weight entry or regimen selection. For example, 1200 mg corresponds to about 17.1 mg/kg at 70 kg and 13.3 mg/kg at 90 kg. Large deviations from typical ranges should trigger protocol review rather than automatic adjustment.
Preparation volume and concentration checks
The calculator estimates drug volume using a 60 mg/mL solution and then derives an estimated final concentration from the chosen infusion bag volume. Concentration matters for stability, administration feasibility, and local compounding policy. If the estimated concentration falls outside a commonly referenced post‑dilution range (approximately 3.2–16.8 mg/mL), adjust the bag volume per institutional guidance and confirm compatible diluents.
Vial planning and waste awareness
Using available vial strengths, selecting a combination that meets or slightly exceeds the target dose can reduce avoidable waste and support inventory planning. The tool searches combinations of 1200 mg and 840 mg vials to minimize excess milligrams, then reports both total prepared amount and projected waste. Always apply your facility’s rules on vial sharing, beyond‑use dating, and hazardous drug handling.
Infusion operations and documentation
Operationally, initial infusions are often scheduled longer than subsequent infusions if prior doses were tolerated. Documenting the dose, bag volume, and vial plan helps align ordering, compounding, and nursing administration steps. The built‑in log supports repeat calculations across visits, and exportable CSV/PDF outputs can be attached to clinical notes or pharmacy worksheets after independent verification.
FAQs
1) Does this tool prescribe or validate a regimen?
No. It formats calculations and planning outputs only. Regimen selection must come from the current label, your institution’s protocol, and pharmacist/oncologist verification.
2) When should I use fixed dosing versus weight-based estimation?
Use fixed schedules when they match the intended regimen. The weight-based option is a legacy estimator for context and should not override modern fixed-dose protocols unless your guideline explicitly requires it.
3) Why does the calculator warn about concentration?
Final concentration can affect preparation feasibility and policy limits. If the estimate is outside typical post-dilution ranges, change bag volume and confirm diluent, stability, and administration instructions per protocol.
4) How is vial selection determined?
The tool tests combinations of 1200 mg and 840 mg vials to meet or exceed the target dose with minimal waste, then reports total prepared milligrams and estimated excess.
5) Can I document multiple visits?
Yes. Use “Add to Log” after each calculation, then export the table to CSV or PDF. Always confirm values independently before attaching exports to clinical records.
6) What patient factors are not handled here?
The tool does not assess indication eligibility, lab thresholds, immune-related toxicity management, drug interactions, or infusion reaction pathways. Those decisions require clinical assessment, grading, and protocol-directed actions.